AbbVie
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AbbVie and other ETFs, options, and stocks.About ABBV
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions.
ABBV Key Statistics
ABBV News
Guggenheim raised the firm’s price target on AbbVie (ABBV) to $214 from $212 and keeps a Buy rating on the shares after updating its company model following the...
Stocks slump after Trump tariff talk sparks huge reversal Stocks reversed gains, hitting the skids on Friday after the White House press secretary confirmed th...
AbbVie (ABBV) is up 7.8%, or $13.78 to $189.43. Invest with Confidence: Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average ret...
Analyst ratings
65%
of 31 ratingsMore ABBV News
AbbVie Inc. ABBV shares are trading higher on Friday. The company reported fourth-quarter adjusted earnings per share of $2.16, beating the street view of $2.11...
AbbVie climbs on new immunology drug sales Pharmaceutical company Abbvie’s share price rose in early trading after it reported better-than-expected earnings an...
AbbVie Inc.’s stock rose 5% early Friday to lead S&P 500 gainers premarket, after the drug company beat fourth-quarter earnings estimates and offered an upbeat...
AbbVie (NYSE:ABBV) traded higher in the premarket on Friday after setting its 2025 earnings outlook in line with expectations even as it reported a loss of $22M...
